Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
A longitudinal cohort study of sexually active women 18-30 years of age was conducted to identify variables associated with the acquisition of herpes simplex virus type 2 (HSV-2) infections. Six hundred seventy HSV-2-seronegative women were followed up at 4-month intervals for 1 year; acquisition of HSV-2 antibodies was detected in 32 of these women. Black race, < or =12 years of education, having a new sex partner, and bacterial vaginosis (BV) were associated with HSV-2 seroconversion on univariate analysis. Antecedent HSV-1 infection was not protective against HSV-2 acquisition. After controlling for other identified risk factors in multivariable models, the diagnosis of BV remained associated with an increased risk of acquiring HSV-2 infection (hazard ratio, 2.1; 95% confidence interval, 1.0-4.5; P=.05). In this study, the population attributable risk of BV for HSV-2 seroconversion was 21%. Additional studies are needed to determine whether screening and treatment of BV could reduce susceptibility to the acquisition of HSV-2 in women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As the normal vaginal microbiota is protective against the acquisition of STI,26–29 and HIV,30 31 menstrual cups may have the potential to reduce the incidence of such infections in vulnerable girls and the spread to their partners.”
Citations
Cites
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,331 · cited 1×
“Vaginal smears were Gram-stained and evaluated for BV according to a standardized 0–10-point scoring system [10].”
MethodSelf-citationThe social organization of sexuality: sexual practices in the United States
(1995) · Choice Reviews Online · doi:10.5860/choice.32-4802a · Cited by 2,890
Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K., & St. Louis, M. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371601 · Cited by 1,189
Martin, H. L., Richardson, B. A., Nyange, P. M., Lavreys, L., Hillier, S. L., Chohan, B., Mandaliya, K., Ndinya‐Achola, J. O., Bwayo, J., & Kreiss, J. (1999) · The Journal of Infectious Diseases · doi:10.1086/315127 · Cited by 891
Self-citationHIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
Sewankambo, N., Gray, R. H., Wawer, M. J., Paxton, L., McNairn, D., Wabwire-Mangen, F., Serwadda, D., Li, C., Kiwanuka, N., Hillier, S. L., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01063-5 · Cited by 655 · cited 1×
“Because the prevalence of BV among women in some communities can be as high as 50% [14], it seems likely that more-comprehensive screening and appropriate treatment of BV would reduce susceptibility to the acquisition of HSV-2 among women.”
BackgroundSelf-citationBacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV
Taha, T. E., Hoover, D. R., Dallabetta, G. A., Kumwenda, N. I., Mtimavalye, L. A. R., Yang, L.-P., Liomba, G. N., Broadhead, R. L., Chiphangwi, J. D., & Miotti, P. G. (1998) · AIDS · doi:10.1097/00002030-199813000-00019 · Cited by 634
Diffusion of Macromolecules and Virus-Like Particles in Human Cervical Mucus
Olmsted, S. S., Padgett, J. L., Yudin, A. I., Whaley, K. J., Moench, T. R., & Cone, R. A. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75844-4 · Cited by 544 · cited 1×
“In vitro, cervical mucus has demonstrated the ability to trap HSV in its viscous gel [17].”
BackgroundAshley, R. L., Militoni, J., Lee, F., Nahmias, A., & Corey, L. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.4.662-667.1988 · Cited by 541 · cited 1×
“For samples in which antibodies to HSV-2 were found by ELISA (and on serum samples from the visits that immediately preceded and followed ELISA seroconversion), Western blot (WB) analysis was performed by the University of Washington Virology Laboratory (Seattle), using methods described elsewhere [12].”
MethodA Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2
Langenberg, A. G. M., Corey, L., Ashley, R. L., Leong, W. P., & Straus, S. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911043411904 · Cited by 510 · cited 1×
“Likewise, the Chiron HSV Vaccine Study Group found that previous HSV-1 infection increased the likelihood of asymptomatic HSV-2 seroconversion but did not reduce the rate of HSV-2 acquisition [23].”
Virologic Characteristics of Subclinical and Symptomatic Genital Herpes Infections
Wald, A., Zeh, J., Selke, S., Ashley, R. L., & Corey, L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509213331205 · Cited by 507 · cited 1×
“sociated with higher rates of vaginal shedding of virus [13].”
Background
Research works printed but not linked: 3
- Mindel, 1996, Scandinavian journal of infectious diseases. Supplementum, 100, 27
- Mertz, 1992, Annals of Internal Medicine, 116, 197, 10.1059/0003-4819-116-3-197 · doi:10.1059/0003-4819-116-3-197
- Siegel, 1992, JAMA, 268, 1702, 10.1001/jama.1992.03490130090036 · doi:10.1001/jama.1992.03490130090036
Cited by
Vaginal microbiome of reproductive-age women
Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S. K., McCulle, S. L., Karlebach, S., Gorle, R., Russell, J., Tacket, C. O., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002611107 · Cited by 4,254
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
“As a result, the vaginal Lactobacilli is considered a risk factor of sexually transmitted infections such as human immunodeficiency virus (HIV),(49) human papillomavirus,(50) and herpes simplex virus infections.(51) In a previous randomized clinical study, Schwebke et al.”
BackgroundRomero, R., Hassan, S. S., Gajer, P., Tarca, A. L., Fadrosh, D. W., Nikita, L., Galuppi, M., Lamont, R. F., Chaemsaithong, P., Miranda, J., et al. (2014) · Microbiome · doi:10.1186/2049-2618-2-4 · Cited by 852
“High Nugent scores or changes in the vaginal microbiota have been associated with increased risk of sexually transmitted infections [20,127-138], including HIV [10,14,22,99,139-150], preterm birth [62,108,151-203], and adverse perinatal outcomes such as post-abortal sepsis [204], early and late miscarriage [165,205,20…”
BackgroundThe Vaginal Microenvironment: The Physiologic Role of Lactobacilli
Amabebe, E., & Anumba, D. O. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00181 · Cited by 785
Koumans, E. H., Sternberg, M., Bruce, C., McQuillan, G., Kendrick, J., Sutton, M., & Markowitz, L. E. (2007) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318074e565 · Cited by 761
Sexually transmitted infections: challenges ahead
Unemo, M., Bradshaw, C. S., Hocking, J. S., de Vries, H. J. C., Francis, S. C., Mabey, D., Marrazzo, J. M., Sonder, G. J. B., Schwebke, J. R., Hoornenborg, E., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30310-9 · Cited by 751
Vaginal Microbiome: Rethinking Health and Disease
Ma, B., Forney, L. J., & Ravel, J. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092611-150157 · Cited by 729
“BV has been shown to be an independent risk factor for the acquisition of sexually transmitted infections (19; 69; 83; 118), the acquisition and transmission of HIV (20–22; 69; 103; 105), the development of pelvic inflammatory disease (PID) (76), as well as reproductive tract and obstetric sequelae (37; 39; 49; 71; 72…”
(2013) · Menopause · doi:10.1097/gme.0b013e3182a122c2 · Cited by 560
Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota
O’Hanlon, D. E., Moench, T. R., & Cone, R. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080074 · Cited by 547
“Lactic acid has been shown to inactivate a wide range of other reproductive tract pathogens, including HSV-2 [28], N. gonorrhoeae [29], and uropathogenic Escherichia coli [30].”
Differences in vaginal microbiome in African American women versus women of European ancestry
Fettweis, J. M., Brooks, J. P., Serrano, M. G., Sheth, N. U., Girerd, P. H., Edwards, D. J., Strauss, J. F., the Vaginal Microbiome Consortium, Jefferson, K. K., & Buck, G. A. (2014) · Microbiology · doi:10.1099/mic.0.081034-0 · Cited by 535
“, 2004), increased risk for acquisition and transmission of HIV and other sexually transmitted diseases (Cherpes et al., 2003; Coleman et al., 2007; Martin et al., 1999; Schwebke, 2003; Wiesenfeld et al., 2003), and increased risk for adverse pregnancy outcomes, including intrauterine infection, early miscarriage, pre…”
Background(2020) · Menopause · doi:10.1097/gme.0000000000001609 · Cited by 531
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health
Petrova, M. I., Lievens, E., Malik, S., Imholz, N., & Lebeer, S. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00081 · Cited by 523
“Nevertheless, a close and regular monitoring of women harboring a diverse type of VMB might be warranted to reduce the risk of BV, STIs or other problems in apparently healthy women, but who might have problems with fertility and preterm delivery.”
BackgroundLamont, R., Sobel, J., Akins, R., Hassan, S., Chaiworapongsa, T., Kusanovic, J., & Romero, R. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02840.x · Cited by 481
The global epidemiology of bacterial vaginosis: a systematic review
Kenyon, C., Colebunders, R., & Crucitti, T. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.05.006 · Cited by 464
The Female Vaginal Microbiome in Health and Bacterial Vaginosis
Chen, X., Lu, Y., Chen, T., & Li, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.631972 · Cited by 451
“Women with BV are at higher risk of acquiring HSV-2 compared with those without BV (Cherpes et al., 2003a; Cherpes et al., 2003b; Cherpes et al., 2005).”
BackgroundThe vaginal microbiota, host defence and reproductive physiology
Smith, S. B., & Ravel, J. (2017) · The Journal of Physiology · doi:10.1113/jp271694 · Cited by 441
“…between CST-IV (as established by Nugent-BV) and increased risk to sexually transmitted infections (Martin et al. 1999; Peters et al. 2000; Cherpes et al. 2003), including human immunodeficiency virus (HIV) (Cohen et al. 1995; Taha et al. 1998; Cu-Uvin et al. 2001; Coleman et al. 2007),…”
BackgroundRuiz-Perez, D., Guan, H., Madhivanan, P., Mathee, K., & Narasimhan, G. (2020) · BMC Bioinformatics · doi:10.1186/s12859-019-3310-7 · Cited by 426
Brotman, R. M., Klebanoff, M. A., Nansel, T. R., Yu, K. F., Andrews, W. W., Zhang, J., & Schwebke, J. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/657320 · Cited by 418
“5]) [6] and development of pelvic inflammatory disease (rate ratio, 2.”
BackgroundLactobacilli Dominance and Vaginal pH: Why Is the Human Vaginal Microbiome Unique?
Miller, E. A., Beasley, D. E., Dunn, R. R., & Archie, E. A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01936 · Cited by 401
“…high vaginal pH (>4.5; Aldunate et al., 2015), infertility, preterm birth, maternal infections, and increased risk of sexually transmitted diseases (Cherpes et al., 2003; Leitich et al., 2003; Atashili et al., 2008; Brotman et al., 2010; van Oostrum et al., 2013; DiGiulio et al., 2015;…”
BackgroundInfluentialAldunate, M., Srbinovski, D., Hearps, A. C., Latham, C. F., Ramsland, P. A., Gugasyan, R., Cone, R. A., & Tachedjian, G. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00164 · Cited by 387
“Lactic acid potently inactivates STIs while lactic acid-producers, such as Lactobacillus, generate a non-inflammatory environment.”
BackgroundInfluentialNanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses
Lai, S. K., Wang, Y.-Y., Hida, K., Cone, R., & Hanes, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911748107 · Cited by 384
“Importantly, women with BV are at markedly increased risks of infection by various sexually transmitted pathogens, such as HIV-1 (53, 54) and HSV-2 (55).”
BackgroundTowards a deeper understanding of the vaginal microbiota
France, M., Alizadeh, M., Brown, S., Ma, B., & Ravel, J. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01083-2 · Cited by 382
Ravel, J., Moreno, I., & Simón, C. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.10.019 · Cited by 370
Ravel, J., Brotman, R. M., Gajer, P., Ma, B., Nandy, M., Fadrosh, D. W., Sakamoto, J., Koenig, S. S., Fu, L., Zhou, X., et al. (2013) · Microbiome · doi:10.1186/2049-2618-1-29 · Cited by 353
“BV has been shown to be an independent risk factor for adverse outcomes, including preterm delivery and low infant birth weight, the development of pelvic inflammatory disease [6] and increased risk of acquiring sexually transmitted infections and HIV [7-10].”
BackgroundMolecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis
Ling, Z., Kong, J., Liu, F., Zhu, H., Chen, X., Wang, Y., Li, L., Nelson, K. E., Xia, Y., & Xiang, C. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-488 · Cited by 345
“Watts DH, Fazzari M, Minkoff H, Hillier SL, Sha B, Glesby M, Levine AM, Burk R, Palefsky JM, Moxley M, Ahdieh-Grant L, Strickler HD: Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1uninfected women.”
BackgroundInfluentialAssociation of the Vaginal Microbiota with Human Papillomavirus Infection in a Korean Twin Cohort
Lee, J. E., Lee, S., Lee, H., Song, Y.-M., Lee, K., Han, M. J., Sung, J., & Ko, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063514 · Cited by 340
“A healthy microbiota prevents or hinders many urogenital diseases, such as yeast infections, sexually transmitted infections, urinary tract infections, and human immunodeficiency virus (HIV) infection [2,3,4,5,6].”
BackgroundSwidsinski, A., Mendling, W., Loening-Baucke, V., Swidsinski, S., Dörffel, Y., Scholze, J., Lochs, H., & Verstraelen, H. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.06.039 · Cited by 335
Metabolic Signatures of Bacterial Vaginosis
Srinivasan, S., Morgan, M. T., Fiedler, T. L., Djukovic, D., Hoffman, N. G., Raftery, D., Marrazzo, J. M., & Fredricks, D. N. (2015) · mBio · doi:10.1128/mbio.00204-15 · Cited by 303
“(%) Vaginal dischargei Normal 18 (30) 5 (13) 13 (65) 18 (30) 0 (0) 18 (90) Abnormal 35 (58) 34 (85) 1 (5) 35 (58) 34 (85) 1 (5) Other 7 (11) 1 (3) 6 (30) 7 (12) 6 (15) 1 (5) pH 4.”
Sherrard, J., Wilson, J., Donders, G., Mendling, W., & Jensen, J. S. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462418785451 · Cited by 297
Borgdorff, H., Tsivtsivadze, E., Verhelst, R., Marzorati, M., Jurriaans, S., Ndayisaba, G. F., Schuren, F. H., & van de Wijgert, J. H. H. M. (2014) · The ISME Journal · doi:10.1038/ismej.2014.26 · Cited by 287
“Furthermore, relationships between BV by Nugent scoring and herpes simplex virus type 2 (HSV-2; Cherpes et al., 2003), Neisseria gonorrhoeae, Chlamydia trachomatis (Wiesenfeld et al.”
MethodVaginal microbiome and sexually transmitted infections: an epidemiologic perspective
Brotman, R. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57172 · Cited by 283
Sobel, J. D., Ferris, D., Schwebke, J., Nyirjesy, P., Wiesenfeld, H. C., Peipert, J., Soper, D., Ohmit, S. E., & Hillier, S. L. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.11.041 · Cited by 281
Self-citationInnate Immunity and Human Milk
Newburg, D. S. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.5.1308 · Cited by 269
Mechanisms and therapeutic effectiveness of lactobacilli
Di Cerbo, A., Palmieri, B., Aponte, M., Morales-Medina, J. C., & Iannitti, T. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-202976 · Cited by 266
Cherpes, T. L., Hillier, S. L., Meyn, L. A., Busch, J. L., & Krohn, M. A. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318156a5d0 · Cited by 251
Self-citationFree Glycogen in Vaginal Fluids Is Associated with Lactobacillus Colonization and Low Vaginal pH
Mirmonsef, P., Hotton, A. L., Gilbert, D., Burgad, D., Landay, A., Weber, K. M., Cohen, M., Ravel, J., & Spear, G. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102467 · Cited by 249
“Women with a genital microbiota dominated by lactobacilli are at significantly lower risk of acquisition of HIV, HSV-2, and several other sexually transmitted pathogens, including Neisseria gonorrhoeae and Chlamydia trachomatis [14–18].”
BackgroundLewis, F. M. T., Bernstein, K. T., & Aral, S. O. (2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001932 · Cited by 248
Current Treatment of Bacterial Vaginosis—Limitations and Need for Innovation
Bradshaw, C. S., & Sobel, J. D. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw159 · Cited by 245
The Microbiota of the Vagina and Its Influence on Women’s Health and Disease
Martin, D. H. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31823ea228 · Cited by 242
Ecological dynamics of the vaginal microbiome in relation to health and disease
Greenbaum, S., Greenbaum, G., Moran-Gilad, J., & Weintraub, A. Y. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.11.1089 · Cited by 239
Shipitsyna, E., Roos, A., Datcu, R., Hallén, A., Fredlund, H., Jensen, J. S., Engstrand, L., & Unemo, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060670 · Cited by 238
“[7], [8], cervicitis [9], [10] and increased susceptibility to infection with various pathogens, such as Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, HSV-2 and HIV [11], [12], [13],”
BackgroundSpear, G. T., French, A. L., Gilbert, D., Zariffard, M. R., Mirmonsef, P., Sullivan, T. H., Spear, W. W., Landay, A., Micci, S., Lee, B.-H., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu231 · Cited by 216
“with a lowered risk of acquiring other sexually transmitted diseases (STDs), such as herpes simplex virus type 2, chlamydia, and gonorrhea [15, 16].”
BackgroundThe Human Microbiome: From Symbiosis to Pathogenesis
Eloe-Fadrosh, E. A., & Rasko, D. A. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-010312-133513 · Cited by 210
Phillips-Howard, P. A., Nyothach, E., ter Kuile, F. O., Omoto, J., Wang, D., Zeh, C., Onyango, C., Mason, L., Alexander, K. T., Odhiambo, F. O., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-013229 · Cited by 209
Watts, D. H., Fazarri, M., Minkoff, H., Hillier, S. L., Sha, B., Glesby, M., Levine, A. M., Burk, R., Palefsky, J. M., Moxley, M., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/427777 · Cited by 207
“transmitted infections (STIs), including those caused by HIV, CT, Neisseria gonorrhoeae, and HSV [24-26].”
BackgroundSelf-citationFrancis, S. C., Mthiyane, T. N., Baisley, K., Mchunu, S. L., Ferguson, J. B., Smit, T., Crucitti, T., Gareta, D., Dlamini, S., Mutevedzi, T., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002512 · Cited by 204
Anzivino, E., Fioriti, D., Mischitelli, M., Bellizzi, A., Barucca, V., Chiarini, F., & Pietropaolo, V. (2009) · Virology Journal · doi:10.1186/1743-422x-6-40 · Cited by 198
“In addition, ethnicity, poverty, cocaine abuse, earlier onset of sexual activity, sexual behaviour and bacterial vaginosis can facilitate a woman's risk of infection before pregnancy [1,18,19].”
BackgroundColonization of the Rectum by Lactobacillus Species and Decreased Risk of Bacterial Vaginosis
Antonio, M. A. D., Rabe, L. K., & Hillier, S. L. (2005) · The Journal of Infectious Diseases · doi:10.1086/430926 · Cited by 196
“2 in women [11, 13, 14], and preterm birth [15].”
BackgroundSelf-citationMastromarino, P., Macchia, S., Meggiorini, L., Trinchieri, V., Mosca, L., Perluigi, M., & Midulla, C. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02112.x · Cited by 194
“that BV facilitates the acquisition of sexually transmitted diseases such as human immunodeficiency virus (HIV), herpes simplex virus type 2, Neisseria gonorrhoeae and Chlamydia trachomatis infection [17–20].”
BackgroundMaternal Microbiome and Pregnancy Outcomes That Impact Infant Health: A Review
Dunlop, A. L., Mulle, J. G., Ferranti, E. P., Edwards, S., Dunn, A. B., & Corwin, E. J. (2015) · Advances in Neonatal Care · doi:10.1097/anc.0000000000000218 · Cited by 190
Herpes simplex virus and HIV-1: deciphering viral synergy
Van de Perre, P., Segondy, M., Foulongne, V., Ouedraogo, A., Konate, I., Huraux, J.-M., Mayaud, P., & Nagot, N. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70181-6 · Cited by 189
Brotman, R. M., Bradford, L. L., Conrad, M., Gajer, P., Ault, K., Peralta, L., Forney, L. J., Carlton, J. M., Abdo, Z., & Ravel, J. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182631c79 · Cited by 182
Barrientos-Durán, A., Fuentes-López, A., de Salazar, A., Plaza-Díaz, J., & García, F. (2020) · Nutrients · doi:10.3390/nu12020419 · Cited by 181
“Initial research by Cherpes and colleagues—in a study with 670 women during a year—found that the BV diagnosis was related with a double risk of HSV-2 seroconversion [11].”
Antimicrobial resistance associated with the treatment of bacterial vaginosis
Beigi, R. H., Austin, M. N., Meyn, L. A., Krohn, M. A., & Hillier, S. L. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.05.033 · Cited by 180
Self-citationLebeau, A., Bruyère, D., Roncarati, P., Peixoto, P., Hervouet, É., Cobraiville, G., Taminiau, B., Masson, M., Gallego, C., Mazzucchelli, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28724-8 · Cited by 184
Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis
Brotman, R. M., Ravel, J., Cone, R. A., & Zenilman, J. M. (2010) · Sexually Transmitted Infections · doi:10.1136/sti.2009.040592 · Cited by 166
The epidemiology of bacterial vaginosis in relation to sexual behaviour
Verstraelen, H., Verhelst, R., Vaneechoutte, M., & Temmerman, M. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-81 · Cited by 190
“second category, BV renders women particularly vulnerable to the acquisition of Trichomonas vaginalis, Neisseria gonorrhoeae [10,11], Chlamydia trachomatis [11], HSV-2 [12] and HIV-1 [13-15].”
BackgroundInfluentialDeveloping animal models for polymicrobial diseases
Bakaletz, L. O. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro928 · Cited by 162
“Recently, BV has also been found to be associated with an increased risk of HSV-2 infectio”
BackgroundThe Vaginal Microbiome in Health and Disease—What Role Do Common Intimate Hygiene Practices Play?
Holdcroft, A. M., Ireland, D. J., & Payne, M. S. (2023) · Microorganisms · doi:10.3390/microorganisms11020298 · Cited by 157
Bacterial vaginosis: a review on clinical trials with probiotics.
Mastromarino, P., Vitali, B., & Mosca, L. (2013) · PubMed · Cited by 199
Kaul, R., Pettengell, C., Sheth, P. M., Sunderji, S., Biringer, A. B., MacDonald, K. S., Walmsley, S. L., & Rebbapragada, A. (2007) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2007.02.002 · Cited by 155
“For instance, bacterial vaginosis, which is essentially an imbalance in the vaginal microflora, is associated with reactivation of both CMV and HSV2, and the direct of causality is not always clear (Cherpes et al., 2003; Ross et al., 2005).”
BackgroundHealthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span
Lehtoranta, L., Ala‐Jaakkola, R., Laitila, A., & Maukonen, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.819958 · Cited by 166
Łaniewski, P., & Herbst‐Kralovetz, M. M. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00259-8 · Cited by 154
Innate Host Defense of Human Vaginal and CervicalMucosae
Cole, A. M. (2006) · Springer eBooks · doi:10.1007/3-540-29916-5_8 · Cited by 165
Spear, G. T., Sikaroodi, M., Zariffard, M. R., Landay, A. L., French, A. L., & Gillevet, P. M. (2008) · The Journal of Infectious Diseases · doi:10.1086/591942 · Cited by 144
“BV is also associated with increased susceptibility to infection with herpes simplex virus type 2, gonorrhea, Trichomonas vaginalis, and Chlamydia trachomatis [10-13].”
Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy
Heinemann, C., & Reid, G. (2005) · Canadian Journal of Microbiology · doi:10.1139/w05-070 · Cited by 142
“The net effect is still a protective effect against UTI and sexually transmitted diseases (Bruce et al. 1973; Reid et al. 1995; Sewankambo et al. 1997; Cherpes et al. 2003).”
BackgroundNardini, P., Palomino, R. A. Ñ., Parolin, C., Laghi, L., Foschi, C., Cevenini, R., Vitali, B., & Marangoni, A. (2016) · Scientific Reports · doi:10.1038/srep29024 · Cited by 143
Herpes Simplex Virus Infection in Pregnancy
Straface, G., Selmin, A., Zanardo, V., Santis, M. D., Ercoli, A., & Scambia, G. (2012) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2012/385697 · Cited by 174
“In addition, ethnicity, poverty, cocaine abuse, earlier onset of sexual activity, sexual behavior, and bacterial vaginosis can facilitate a woman’s risk of infection before pregnancy [10, 11].”
Roles of the Microbiota of the Female Reproductive Tract in Gynecological and Reproductive Health
Zhu, B., Tao, Z., Edupuganti, L., Serrano, M. G., & Buck, G. A. (2022) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00181-21 · Cited by 156
“risk for acquisition of STIs, including HIV (55), herpes simplex virus (HSV) (128), human”
BackgroundGynecologic health and disease in relation to the microbiome of the female reproductive tract
Green, K. A., Zarek, S. M., & Catherino, W. H. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.10.010 · Cited by 139
Etiology of bacterial vaginosis and polymicrobial biofilm formation
Jung, H.-S., Ehlers, M. M., Lombaard, H., Redelinghuys, M. J., & Kock, M. M. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1291579 · Cited by 123
“Finally, sialidase and prolidase may also contribute to the degradation and detachment of vaginal epithelium and mucins, as well as the increase of IL-1b, IL-8 and TNF-a that makes the host more susceptible to human immunodeficiency virus 1 (HIV-1) (Cauci et al., 2008; Sturm-Ramirez et al., 2000) and herpes simplex vi…”
BackgroundKaul, R., Nagelkerke, N. J., Kimani, J., Ngugi, E., Bwayo, J. J., MacDonald, K. S., Rebbaprgada, A., Fonck, K., Temmerman, M., Ronald, A. R., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/522006 · Cited by 134
“BV has been associated with an increased incidence of bacterial STIs [10] and HSV-2 infection [9].”
BackgroundSeverity of bacterial vaginosis and the risk of sexually transmitted infection
Allsworth, J. E., & Peipert, J. F. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.02.060 · Cited by 133
“[2–10] In prospective studies, BV has been shown to increase the odds of HIV acquisition [11]–[12]as well as herpes simplex virus (type 2).[13] As these prospective studies highlight, there are multiple common approaches for defining the presence of BV.”
The primate vaginal microbiome: Comparative context and implications for human health and disease
Stumpf, R. M., Wilson, B. A., Rivera, A. J., Yıldırım, S., Yeoman, C. J., Polk, J. D., White, B. A., & Leigh, S. R. (2013) · American Journal of Physical Anthropology · doi:10.1002/ajpa.22395 · Cited by 139
Mirmonsef, P., Hotton, A. L., Gilbert, D., Gioia, C. J., Maric, D., Hope, T. J., Landay, A. L., & Spear, G. T. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153553 · Cited by 120
Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda
Liu, C. M., Hungate, B. A., Tobian, A. A. R., Ravel, J., Prodger, J. L., Serwadda, D., Kigozi, G., Galiwango, R. M., Nalugoda, F., Keim, P., et al. (2015) · mBio · doi:10.1128/mbio.00589-15 · Cited by 123
“Nugent-BV can be interpreted in the context of its epidemiological associations (9, 12, 17, 18, 21, 22).”
BackgroundMicrobiota and Pelvic Inflammatory Disease
Sharma, H., Tal, R., Clark, N. A., & Segars, J. H. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0033-1361822 · Cited by 141
for the Vaginal Biomarkers Study Group, Jespers, V., van de Wijgert, J., Cools, P., Verhelst, R., Verstraelen, H., Delany-Moretlwe, S., Mwaura, M., Ndayisaba, G. F., Mandaliya, K., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0825-z · Cited by 119
“BV can increase the risk of other STI which are in turn associated with HIV acquisition, including human papilloma virus and herpes simplex virus type 2 (HSV-2) infection [5-7].”
BackgroundRomero, R., Hassan, S. S., Gajer, P., Tarca, A. L., Fadrosh, D. W., Nikita, L., Galuppi, M., Lamont, R. F., Chaemsaithong, P., Miranda, J., et al. (2014) · Microbiome · doi:10.1186/2049-2618-2-10 · Cited by 118
Cigarette smoking is associated with an altered vaginal tract metabolomic profile
Nelson, T. M., Borgogna, J. C., Michalek, R. D., Roberts, D. W., Rath, J. M., Glover, E. D., Ravel, J., Shardell, M. D., Yeoman, C. J., & Brotman, R. M. (2018) · Scientific Reports · doi:10.1038/s41598-017-14943-3 · Cited by 122
Bitew, A., Abebaw, Y., Bekele, D., & Mihret, A. (2017) · International Journal of Microbiology · doi:10.1155/2017/4919404 · Cited by 143
“Furthermore, it increases the risk of acquiring (i) human immunodeficiency virus [5] and other sexually transmitted infections (STI), such as gonorrhea, trichomoniasis, and herpes simplex virus type 2 (HSV-2) [6, 7], and (ii) miscarriage, preterm labor, preterm delivery, and postpartum complications such as endometrit…”
Bacterial vaginosis: an overview for 2009.
Livengood, C. H. (2009) · PubMed · Cited by 173
Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms
Hapgood, J. P., Kaushic, C., & Hel, Z. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00103 · Cited by 112
The genital econiche: focus on microbiota and bacterial vaginosis
Danielsson, D., Teigen, P. K., & Moi, H. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06041.x · Cited by 110
Petrina, M. A. B., Cosentino, L. A., Rabe, L. K., & Hillier, S. L. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.05.005 · Cited by 120
Self-citationMaking inroads into improving treatment of bacterial vaginosis – striving for long-term cure
Bradshaw, C. S., & Brotman, R. M. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1027-4 · Cited by 109
“Longitudinal studies have demonstrated that BV is associated with an approximate 2-fold increased risk of acquiring sexually transmitted infections including chlamydia, gonorrhoea, herpes simplex type 2 and HIV infection [6–11], and increases the risk of co-infected women transmitting HIV to their male partners [12].”
BackgroundEl Aila, N. A., Tency, I., Claeys, G., Verstraelen, H., Saerens, B., Lopes dos Santos Santiago, G., De Backer, E., Cools, P., Temmerman, M., Verhelst, R., et al. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-167 · Cited by 119
Inhibition of herpes simplex virus type 2 by vaginal lactobacilli.
Conti, C., Malacrino, C., & Mastromarino, P. (2009) · PubMed · Cited by 115
Brotman, R. M., Ravel, J., Bavoil, P. M., Gravitt, P. E., & Ghanem, K. G. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.10.010 · Cited by 108
Bayigga, L., Kateete, D. P., Anderson, D. J., Sekikubo, M., & Nakanjako, D. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.10.014 · Cited by 123
“47 Therefore, high presence of G vaginalis is a probable indicator of BV. Pregnant women had higher Lactobacillus concentrations (7.01 genome equivalents/mL) relative to nonpregnant HIV-negative women –6.08 genome equivalents/mL. 48 In summary, vaginal microbiota communities in sub-Sahara African women have lesser abu…”
BackgroundInfluentialSchwebke, J. R., & Desmond, R. A. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.02.048 · Cited by 121
Antonio, M. A. D., Meyn, L. A., Murray, P. J., Busse, B., & Hillier, S. L. (2009) · The Journal of Infectious Diseases · doi:10.1086/598686 · Cited by 108
Self-citationShannon, B., Gajer, P., Yi, T. J., Ma, B., Humphrys, M. S., Thomas‐Pavanel, J., Chieza, L., Janakiram, P., Saunders, M. A., Tharao, W. E., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix088 · Cited by 113
The vaginal microbiota and susceptibility to HIV
Buvé, A., Jespers, V., Crucitti, T., & Fichorova, R. N. (2014) · AIDS · doi:10.1097/qad.0000000000000432 · Cited by 123
Predictors of Bacterial Vaginosis in Adolescent Women Who Douche
Schwebke, J. R., Desmond, R. A., & Oh, M. K. (2004) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000129948.91055.9f · Cited by 108
Jespers, V., Crucitti, T., Menten, J., Verhelst, R., Mwaura, M., Mandaliya, K., Ndayisaba, G. F., Delany-Moretlwe, S., Verstraelen, H., Hardy, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109670 · Cited by 105
“There is some evidence that other RTIs are risk factors for BV [11] and that BV enhances the vulnerability of women to other RTIs [12–14].”
BackgroundCole, A. M., & Cole, A. L. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00561.x · Cited by 118
Nagot, N., Ouedraogo, A., Defer, M.-C., Vallo, R., Mayaud, P., & Van de Perre, P. (2007) · Sexually Transmitted Infections · doi:10.1136/sti.2007.024794 · Cited by 100
Konadu, D. G., Owusu-Ofori, A. K., Yidana, Z., Boadu, F., Iddrisu, L. F., Adu‐Gyasi, D., Dosoo, D., Lartey, R. A., Owusu‐Agyei, S., & Asante, K. P. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2488-z · Cited by 119
Gottlieb, S. L., Douglas, J. M., Foster, M., Schmid, D. S., Newman, D. R., Barón, A. E., BOLAN, G. A., Iatesta, M., Malotte, C. K., Zenilman, J. M., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/423323 · Cited by 112
“These results are consistent with findings from the Chiron vaccine trial [23], 2 prospective trials among females [30, 34], and an evaluation of nationally representative seroprevalence data from 1988 to 1994 [35].”
BackgroundResult
Metadata
- Authors
- Cherpes, T. L., Meyn, L. A., Krohn, M. A., Lurie, J. G., & Hillier, S. L.
- Affiliations
- University of Pittsburgh (US)
- Magee-Womens Research Institute (US)
- Corresponding author
- Meyn, L. A.
- ORCID
- Krohn, M. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-08-01
- Volume
- 37
- Issue
- 3
- Pages
- 319-325
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2095874292
- Cited by
- 415
- References
- 31
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 14 · 2023: 17 · 2022: 23 · 2021: 15 · 2020: 24 · 2019: 22 · 2018: 23 · 2017: 27 · 2016: 22 · 2015: 20 · 2014: 21 · 2013: 28 · 2012: 16
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Washington
- U.S. Public Health Service (N01-A1-75326)
- National Institute of Allergy and Infectious Diseases (T32-AI07333, U01-AI46745, T32AI007333, U01AI046745)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- herpes simplex virus type 2, bacterial vaginosis, HSV-1 infection, Black women, educational attainment, new sexual partners, population attributable risk
- MeSH terms
- Adult, Cross-Sectional Studies, Enzyme-Linked Immunosorbent Assay, Female, Herpes Simplex, Humans, Longitudinal Studies, Pregnancy, Risk Factors, Cohort Studies, Polymerase Chain Reaction, Vaginosis, Bacterial, Herpesvirus 2, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.